Page 22

19544GA

Q1 Issue Threading the Needle With Nanoparticle Technology 142 Kidney Cancer Journal to Improve the Therapeutic Index in RCC Nicholas J. Vogelzang, MD, FASCO, FACP, Stu Chapman Combining Radiation, Immunotherapy Could Emerge as Exciting New Direction With Potential Mechanisms of Synergy Brendan D. Curti, MD KCJ Meeting Report: GU ASCO Highlights ASCO GU Provides Insightful, Provocative Updates on Broad Spectrum of RCC Jose A. Karam, MD, FACS Q2 Issue Kidney Cancer Treatments March into the Future: A Renal Cell Review of ASCO 2016 Marc R. Matrana, MD, MS Suma Satti, MD Case of Primary Renal Carcinoid Tumor in Healthy Military Soldier George Leighton Lee, MD, Lee Andrew Evans, MD, Farrukh I. Gill, MD Active Surveillance for Small Renal Masses: a Review of the Literature and a Focus on the DISSRM Registry Sasha Druskin, MD, Phillip M. Pierorazio, MD Q3 Issue A Promising Hypothesis: Statins + Targeted Therapy May Improve Survival Outcomes in RCC Rana R. McKay, MD Deconstructing the Treatment Algorithm: What Is the Current Thinking on the Decision Tree? Nicholas J. Vogelzang, MD KCJ Case Report: Updated long-term responders with metastatic clear cell kidney cancer to treatment with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib Gautam Jha, Mark DeBenedette, Lee F. Allen, Shawn M. Leland, and Arkadiusz Z. Dudek Q4 Issue Pivotal CABOSUN Trial Reshapes Treatment Options For Intermediate, Poor-RISK RCC Robert A. Figlin, MD, Gisela Schwab, MD, Toni Choueiri, MD S-TRAC and Its Implications: Finally, a New Paradigm for Adjuvant Therapy Emerges Alexandra Dakaki, MD, PhD, Allan Pantuck, MD 2016 Index of Articles in Kidney Cancer Journal, Volume 14


19544GA
To see the actual publication please follow the link above